Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
204.8 SEK | +0.10% | -0.29% | +61.13% |
18/06 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
18/06 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.13% | 104.28Cr | |
+15.72% | 7.75TCr | |
+13.65% | 894.1Cr | |
-24.30% | 428.16Cr | |
+12.79% | 417.67Cr | |
+10.97% | 222.69Cr | |
-30.57% | 206.28Cr | |
+8.99% | 197.09Cr | |
-45.76% | 169.37Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Transcript : Calliditas Therapeutics AB, Q1 2024 Earnings Call, May 23, 2024